Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

KALEO, INC.

UEI: LBM4GLJNDK31CAGE: 5LVP8

KALEO, INC. is a federal contractor, registered under UEI LBM4GLJNDK31 and CAGE code 5LVP8. It has been awarded $137,211,490 in federal contracts. Primary work spans Research and Development in Biotechnology (except Nanobiotechnology), Pharmaceutical Preparation Manufacturing, and Other NAICS codes (1 codes, <0.5% each). Top awarding agencies include Department Of Health And Human Services and Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

LBM4GLJNDK31

CAGE Code

5LVP8

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationManufacturer of Goods

NAICS Codes

325412Pharmaceutical Preparation Manufacturing
541714Research and Development in Biotechnology (except Nanobiotechnology)(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

KALEO, INC. specializes in the development and manufacturing of pharmaceutical preparations and biotechnology-driven medical devices, with a focused expertise in novel drug delivery systems and regulatory-compliant production processes. The company has demonstrated technical proficiency in the formu...

KALEO, INC. specializes in the development and manufacturing of pharmaceutical preparations and biotechnology-driven medical devices, with a focused expertise in novel drug delivery systems and regulatory-compliant production processes. The company has demonstrated technical proficiency in the formulation and scale-up of critical-care injectables, including naloxone and pralidoxime chloride, and has successfully engineered auto-injector devices designed for rapid, reliable administration in emergency settings. Their work integrates pharmaceutical manufacturing standards with device innovation, ensuring compliance with FDA cGMP guidelines and NDC labeling requirements. KALEO’s ability to navigate complex regulatory pathways for both drug substances and combination products positions them as a niche provider in the intersection of pharmaceuticals and medical device development. The contractor maintains a strong working relationship with the Department of Veterans Affairs, delivering essential medications and addressing administrative corrections to drug product identifiers, indicating deep familiarity with VA’s supply chain and formulary management systems. They also support the Department of Health and Human Services on advanced biotech R&D initiatives, particularly in the design of next-generation antidote delivery platforms, reflecting their capacity to engage in mission-critical public health innovation. KALEO’s primary industry focus lies in NAICS 325412 (pharmaceutical preparation manufacturing) and 541714 (biotechnology research and development), where they bridge laboratory-scale innovation with commercial-scale production. Their specialization in antidote and emergency response therapeutics aligns them with federal preparedness and veteran healthcare priorities. As a small business structured as a 2L entity based in Richmond, Virginia, KALEO operates without federal certifications but leverages technical precision and regulatory agility to serve high-stakes government health missions. Their geographic presence and focused capabilities make them a trusted partner for agencies requiring reliable, compliant pharmaceutical and biotech solutions.

Key Performance Metrics

Awards Count

26

All time

Active

2

Currently performing

Completed

24

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with KALEO, INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for KALEO, INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in KALEO, INC.'s top NAICS codes and agencies

NAICS: 325412
New
DIBBS
Epinephrine Injector
Solicitation # SPE2D2-26-R-0009
Solicitation SPE2D2-26-R-0009 is a federal procurement issued by the Defense Logistics Agency Troop Support Medical Supply Chain for the acquisition of Epinephrine 0.3 MG/0.3 ML Injection Auto-Injectors in 2-count boxes. The government is seeking offers from manufacturers or distributors to ensure an uninterrupted supply, with a total contract duration not to exceed five years. The procurement is conducted as a lowest price technically acceptable acquisition, where awards are based on technical acceptability regarding requirements and past performance, followed by the lowest evaluated aggregate price. The estimated quantity for the base year and subsequent option years is 473,905 boxes per period. Offerors must submit their proposals electronically via DIBBS by November 16, 2026. Required documentation includes a signed SF 1449, a price proposal, and either a Letter of Certification for manufacturers or a Letter of Commitment from the manufacturer for dealers and suppliers. Strict quality and regulatory standards apply, including mandatory FDA clearance and compliance with current Good Manufacturing Practices. Packaging must feature child-proof closures, non-glass bottles with a minimum 100cc volume, and GS1-128 or HIBC compliant bar coding at the unit-of-use level encoding the National Drug Code. All contractors must also adhere to the Drug Supply Chain Security Act and various FAR and DFARS clauses regarding trade agreements and cybersecurity.
MEDICAL SUPPLY CHAIN FSGB

POSTED

about 7 hours ago

DEADLINE

in about 1 month
View Details
NAICS: 325412
New
Federal
6505--Lab Supplies - Radiopharm Philadelphia VA Medical Center
Solicitation # 36C24427Q0018
The Department of Veterans Affairs, Network Contracting Office 4, is soliciting quotations for an indefinite-quantity contract to provide essential radiopharmaceuticals and calibration sources for the Corporal Michael J. Crescenz VA Medical Center Nuclear Medicine Department. The contract covers a five-year period of performance from November 1, 2026, to October 31, 2031, consisting of a base year and four option years. The selected vendor must be licensed and accredited by the Nuclear Regulatory Commission and comply with all regulations from the DOT, NHPP, FDA, and OSHA. Deliveries are to be made to a secure location at the medical center, with routine orders due by 8:00 AM the following workday and same-day deliveries required within two hours of order placement during normal business hours. The scope of work includes the supply of various radiopharmaceutical kits and calibration sources, such as Co57 and Tc99m variants. Contractors must ensure all radioactive materials are clearly labeled with proper class and exposure levels, and unit doses must include preparation and expiration details. Additionally, the vendor must provide bar-labeled inserts compatible with the PineStar Nuclear Medicine Information Management System or provide a compatible system, including data migration and training, at no additional cost. Award will be based on a comparative evaluation of price and past performance, with a preference for HUBZone Small Business Concerns. Quotations must be submitted electronically to the Contracting Officer in two parts: a price quotation and past performance information from the last three years. Invoicing is to be handled monthly and submitted electronically via the Austin Payment Center.
244-NETWORK Contract Office 4 (36C244)

POSTED

about 7 hours ago

DEADLINE

in about 24 hours
View Details